The Delhi High Court, on April 27, asked if BJP MP Gautam Gambhir had the license to procure COVID-19 medicines in large quantities and distribute them. Gambhir won the 2019 Lok Sabha Elections from the East Delhi constituency.
The division bench of Justices Vipin Sanghi and Rekha Palli asked how it was possible for anybody to procure such medicines in large quantities, The Indian Express reported.
Follow our LIVE blog for the latest updates of the coronavirus pandemic
Gambhir is distributing ‘Fabiflu’ as he mentioned on Twitter, said Advocate Rakesh Malhotra earlier.
Malhotra also told the court that even though Gambhir was “doing a good job”, it was an issue since patients of East Delhi were getting the drug while some patients of other areas were not getting it.
“I do not know from where he is getting it,” Malhotra said.
Also read | 'Kangana of Cricket': MS Dhoni fans attack Gautam Gambhir
Senior advocate Rahul Mehra said it was “highly irresponsible”. Mehra was representing the Delhi government.
“We had thought it would stop after that report. It is still continuing,” said the court.
The former Indian cricketer tweeted on April 25 that ‘Fabiflu’ would be available for free from the following day. People would require their Aadhaar Card and doctor’s prescription to procure the same, he said.
Gambhir tweeted on April 27 that people outside East Delhi were also eligible for getting the COVID-19 medicine for free.
इस मुश्किल घड़ी में हम सब को एक दुसरे का साथ देना है!कल से हम ‘फ़ैबिफ्लू’ मुफ़्त में GGF कार्यालय (22, पूसा रोड) से भी 10 से 4 के बीच दिल्ली के ज़्यादा से ज़्यादा लोगों को देने की कोशिश करेंगे. अपना आधार और डॉक्टर का पर्चा ले आएं. ऑक्सीजन सिलिंडरों का भी इंतज़ाम किया जा रहा है!
— Gautam Gambhir (@GautamGambhir) April 25, 2021
Want to reiterate that patients outside East Delhi can get ‘Fabiflu’ from GGF office - 22, Pusa Road b/w 10-4 for FREEमैं दोबारा बताना चाहता हूँ की पूर्वी दिल्ली से दूर रहने वाले मरीज़ ‘फ़ैबीफ़्लू’ GGF कार्यालय 22, पूसा रोड से 10-4 के बीच मुफ़्त में ले सकते हैं!
— Gautam Gambhir (@GautamGambhir) April 27, 2021
Follow Moneycontrol’s full coverage of the coronavirus pandemic here